Boehringer Ingelheim

Boehringer Ingelheim is working on breakthrough therapies that transform lives, today and for generations to come. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term perspective. More than 52,000 employees serve over 130 markets in the three business areas, Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing.


Latest Articles

Earthquakes Türkiye & Syria

Earthquakes Türkiye & Syria

Support for those impacted by Türkiye & Syria earthquakes: Additional Türkiye and Syria relief actions raise company contribution to EUR 1 million


Read more
Financial Highlights
About us

Financial Highlights 2021

Net sales, Research and Development expenditures, Operating Income and Personnel Capacity: Boehringer Ingelheim grows
Read more
Annual Report 2021

Annual Report 2021: Tomorrow

Tomorrow holds great opportunities for more progress, more sustainability, and better health. Read inspiring stories on our understanding of a healthier future in our annual report.


Related Press Releases